Pituitary and Adrenal Gland Disorders

Hormonal imbalances originating from the pituitary and adrenal gland disorders significantly affect metabolic regulation, stress response, and glucose homeostasis. Conditions such as Cushing’s syndrome, Addison’s disease, and acromegaly disrupt normal endocrine signaling, contributing to insulin resistance, hypertension, and cardiovascular complications. Advances in endocrinology have led to targeted therapies, including hormone replacement and receptor-specific drugs, to restore balance. Imaging technologies and molecular diagnostics have improved early detection, allowing for timely interventions. Understanding the connections between pituitary-adrenal dysfunction and metabolic diseases enables the development of more precise treatment strategies. Ongoing research continues to refine therapeutic options, offering new hope for patients with complex endocrine disorders.

Committee Members
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes 2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes 2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes 2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes 2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes 2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes 2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp